InvestorsHub Logo
Followers 26
Posts 2881
Boards Moderated 0
Alias Born 12/05/2021

Re: vator post# 521815

Friday, 10/14/2022 8:11:20 AM

Friday, October 14, 2022 8:11:20 AM

Post# of 701779
NWBO, or the company buying NWBO, will have to start other P3 DCVAX trials for other solid tumor organ cancer indications such as lung, liver, prostate etc to prove efficiency and then submit the request for approval.

At the phase the request for approval for GBM is going we are looking well beyond the 2030s for other organ cancers
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News